Condition: Congenital Heart Defect · Single-ventricle · Coarctation of Aorta · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfusion status or abnormal pulmonary blood flow. Near infrared spectroscopy has been used in neonatal intensive care units (NICU) to measure end-organ perfusion. The investigator plan on monitoring newborns with CHD admitted to the NICU with NIRS and echocardiography during the first week of life and correlate measures of perfusion from Dopplers to cerebral and renal NIRS.
This description comes directly from the study's public registry record.
Gabriel Altit, MD · 514-412-4452 · gabriel.altit@mcgill.ca
Jennifer Gardner · 514-412-4400 · jennifer.gardner@muhc.mcgill.ca
Always discuss trial participation with your own doctor first.
| Mcgill University Health Centre | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04106479